Answers are grounded in this paper and cite their sources.
The purpose of this abstract is to provide data on a 27-year-old woman with a rare and rapidly progressive cancer, Nuclear in Testis (NUT) carcinoma (NC), and to highlight possible treatment options for her specific gene translocation of NSD3-NUT. To our knowledge, this is the first case in the literature that was presented initially as anaplastic thyroid cancer. We propose that targeted therapy with a histone lysine methyltransferase inhibitor may be of benefit as adjunctive therapy in patients with the NSD3-NUT gene translocation.
No takes yet. Share an insight, caveat, or question.
Neumann et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: